Morphine sulfate is a strong painkiller used to treat moderate to severe pain, such as pain from cancer, heart attacks, or after surgery. It can also be used to help people with severe shortness of breath.[2] MS Contin is currently approved and in use across 31 indications[4].[1]
MS Contin is one of 709 small molecule programs targeting Low back pain. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
MS Contin
Avastin
Megace
Cymbalta
Lexiscan
Adenocard
Voltaren
Sporanox
Tricor
Avastin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details